Related Experiment Video
Updated: Jul 5, 2026

06:32
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
[Immunity in chronic bronchitis patients with significant residual changes after prior pulmonary tuberculosis]
Summary
Chronic bronchitis patients with residual lung changes from tuberculosis exhibit altered immune cell levels and neutrophil function during exacerbations. Their immune response shows reduced B lymphocytes and impaired microbicidal activity, yet high antioxidative capacity persists.
Area of Science:
- Immunology
- Pulmonology
- Infectious Disease
Background:
- Chronic bronchitis (CB) is a significant respiratory condition.
- Prior pulmonary tuberculosis can lead to great residual changes (GRC) in the lungs.
- Understanding the immunological impact of GRC in CB is crucial for patient management.
Purpose of the Study:
- To investigate the immunological characteristics of CB patients with GRC after pulmonary tuberculosis.
- To compare immune profiles between CB patients with and without a history of tuberculosis.
Main Methods:
- Comparative study design.
- Inclusion of 40 CB patients with GRC post-tuberculosis and 30 CB patients without tuberculosis history.
- Assessment of lymphocyte subsets (T and B cells), neutrophil phagocytic properties, and humoral immune response.
Main Results:
- CB patients with GRC showed higher T lymphocytes and lower B lymphocytes during exacerbation.
- Neutrophil phagocytic activity was altered, with decreased oxygen-dependent microbicidal capacity despite stimulation.
- Humoral response was mildly pronounced, and low serum levels of tuberculosis-active products suggested reduced lipid peroxidation.
Conclusions:
- CB patients with GRC post-tuberculosis display distinct immunological alterations during exacerbations.
- Despite impaired neutrophil microbicidal function, these patients maintain high antioxidative activity.
- Findings highlight the complex interplay between prior tuberculosis, residual lung damage, and immune response in chronic bronchitis.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...